A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors

RECRUITING

Carolina BioOncology Institute /ID# 254305, Huntersville

COMPLETED

Washington University-School of Medicine /ID# 262943, St Louis

RECRUITING

University of Texas MD Anderson Cancer Center /ID# 254308, Houston

RECRUITING

NEXT Oncology /ID# 257395, San Antonio

RECRUITING

South Texas Accelerated Research Therapeutics /ID# 256944, San Antonio

RECRUITING

University of Southern California /ID# 254356, Los Angeles

RECRUITING

City of Hope /ID# 254303, Duarte

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 254606, Jerusalem

RECRUITING

City of Hope - Orange County Lennar Foundation Cancer Center /ID# 266792, Irvine

RECRUITING

Rambam Health Care Campus /ID# 254608, Haifa

RECRUITING

The Chaim Sheba Medical Center /ID# 259408, Ramat Gan

RECRUITING

START Midwest /ID# 256945, Grand Rapids

RECRUITING

NYU Langone - Laura and Isaac Perlmutter Cancer Center /ID# 256943, New York

RECRUITING

The Ohio State University - The James /ID# 260475, Columbus

RECRUITING

National Cancer Center Hospital East /ID# 261712, Kashiwa-shi

RECRUITING

Shizuoka Cancer Center /ID# 261714, Sunto-gun

RECRUITING

National Cancer Center Hospital /ID# 254359, Chuo-ku

RECRUITING

Wakayama Medical University Hospital /ID# 254361, Wakayama